---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-071485"
form_type: "8-K"
ticker: "MREO"
cik: "0001719714"
company_name: "Mereo BioPharma Group plc"
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T09:06:22.861638+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Mereo BioPharma 2025 AGM: all resolutions pass; board elects annual say-on-pay

## Summary
- Resolutions 1-5 and 7-9 passed with over 85% of votes cast.
- Resolution 6 (advisory vote on frequency of exec comp) received 48% for 1-year, 46% for 3-year; board chooses annual frequency until 2031.
- Re-elected directors Deepika Pakianathan, Pierre Jacquet, Michael Wyzga each won >85% support.
- PricewaterhouseCoopers re-appointed as auditor with 99.58% of votes cast.
- Total 624,188,662 ordinary shares represented at the meeting.

## SEC filing metadata
- accession: 0000950170-25-071485
- form_type: 8-K
- ticker: MREO
- cik: 0001719714
- company_name: Mereo BioPharma Group plc
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719714/000095017025071485/0000950170-25-071485-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719714/000095017025071485/mreo-20250513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-071485
- JSON: https://secwatch.observer/filing/0000950170-25-071485.json
- Plain text: https://secwatch.observer/filing/0000950170-25-071485.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.